Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amylyx Pharmaceuticals Inc 43 Thorndike St. Cambridge MA 02141 USA

www.amylyx.com Employees: 123 P: 617-682-0917

Sector:

Medical

Description:

Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,371,652
Enterprise Value, $K 1,294,262
Shares Outstanding, K 109,820
Annual Sales, $ 87,370 K
Annual Net Income, $ -301,740 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -34,390 K
EBIT, $ -157,340 K
EBITDA, $ -166,290 K
60-Month Beta -0.34
% of Insider Shareholders 12.30%
% of Institutional Shareholders 95.84%
Float, K 96,312
% Float 87.70%
Short Interest 11,624
Short Float 10.58%
Short Volume Ratio 0.69

Growth:

1-Year Return 201.97%
3-Year Return -66.20%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/06/25
Next Earnings Date 03/03/26
Earnings Per Share ttm -1.80
EPS Growth vs. Prev Qtr 19.57%
EPS Growth vs. Prev Year 30.19%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 03/28/18
Dividend Payable Date 04/02/18
Dividend Payout Ratio 0.00%

AMLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -68.95%
Return-on-Assets % -61.52%
Profit Margin % -345.36%
Debt/Equity 0.00
Price/Sales 15.47
Price/Cash Flow N/A
Price/Book 4.07
Book Value/Share 3.02
Interest Coverage -1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar